@ds
A question to you. With the subtle re-positioning to an Oncology company, do you think there is a chance that the development of antibiotics and the Genetech deal - is a little more on the back burner - hence the inference of "they will take 12 month to make their mind up - and we will receive a milestone payment regardless"
The focus appears to more towards myc and oncology and drug development, do they have the staff to be working on both this and the genetech deal?
I am interested to hear your take on this.
Thank you
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.005(0.39%) |
Mkt cap ! $740.7M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.29 | $1.27 | $18.92K | 14.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18079 | $1.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 715 | 2 |
View Market Depth
| Last trade - 12.40pm 30/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |